KIND T Cells

· University of California, San Francisco

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KIND T Cells, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma [Phase 1]

See pricing